DGHS approves use of ‘Molnupiravir’ to treat symptomatic Covid-19
"The drug will help to reduce hospitalisation and mortality rates by at least 50%"
THURSDAY, APRIL 23, 2026
"The drug will help to reduce hospitalisation and mortality rates by at least 50%"
